Literature DB >> 11198137

Treatable forms of retinitis pigmentosa associated with systemic neurological disorders.

C A Grant1, E L Berson.   

Abstract

In this chapter; we have described the role of nutritional supplements or selective dietary restriction (or both) on the maintenance and function of the retina and nervous system in some diseases. Oral vitamin A therapy has proven to be effective in the treatment of the common forms of retinitis pigmentosa. Bassen-Kornzweig disease can be treated with vitamin A and vitamin E and, in some cases, with vitamin K. Vitamin E therapy for Friedreich-like ataxia associated with retinitis pigmentosa has been shown to be effective in the short term. Classic Refsum's disease responds to a low phytol-low phytanic acid diet. Undoubtedly, future research will bring more insight into the biochemical pathways responsible for other diseases and, it is hoped, aid in developing treatments for additional retinal degenerations associated with systemic neurological disease.

Entities:  

Mesh:

Year:  2001        PMID: 11198137     DOI: 10.1097/00004397-200101000-00010

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  4 in total

1.  Large Benefit from Simple Things: High-Dose Vitamin A Improves RBP4-Related Retinal Dystrophy.

Authors:  Vasily M Smirnov; Baptiste Wilmet; Marco Nassisi; Christel Condroyer; Aline Antonio; Camille Andrieu; Céline Devisme; Serge Sancho; José-Alain Sahel; Christina Zeitz; Isabelle Audo
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 2.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

Review 3.  Bone marrow-derived stem cells preserve cone vision in retinitis pigmentosa.

Authors:  Lois E H Smith
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

4.  Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].

Authors:  Hossein Bahrami; Michele Melia; Gislin Dagnelie
Journal:  BMC Ophthalmol       Date:  2006-06-07       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.